Pharmacokinetics, safety and tissue residues of sustained‐release sulfamethazine in sheep

M. S. BULGIN, V Michael Lane, T. E. ARCHER, J. D. BAGGOT, A. L. CRAIGMILL

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Concentration‐time profiles and the rates of absorption, extent of distribution and half‐lives of sulfamethazine (SMZ), administered intravenously, orally as a water solution and as a sustained‐release formulation (CalfSpanrr̀) were determined in 10 healthy sheep. The geometric mean half‐life of elimination of i.v. SMZ was 10.8 h, compared to 14.3 h for the sustained‐release preparation (CalfSpanrr̀) and 4.3 h for the oral water solution. Blood levels of SMZ were at or above 50 ng/ml for more than 48 h for CalfSpanr̀, for 24 h after i.v. SMZ (100 mg/kg body wt), and for less than 24 h after p.o. SMZ (100 mg/kg body wt). The mean bioavailability of the oral SMZ solution was 58.3% (AUCp.oJAUCi.v). The estimated bioavailability of the CalfSpanr̀ preparation was 52.5%. The safety of the sustained‐release preparation was tested by dosing sheep with multiples (one, three and five times) of the recommended dose (one tablet, 8 g SMZ, per 20 kg body wt), once a day for 3 days. Clinical blood chemistries showed a significant increase in serum iron, and a decrease in serum phosphorus in animals treated at the 3x and 5x dose levels. Necropsies of the 5x dose animals did not show any gross signs that could be attributed to SMZ, and histological examination of tissues from the 5x animals revealed no organ pathology. Residues of SMZ in liver, fat, kidney and skeletal muscle were measured in 20 animals that received one bolus per 20 kg body wt. The results indicate that SMZ residues are cleared rapidly, and are at or below the tolerance level of 0.1 mg/kg within 8 days after dosing so that the 18‐day withdrawal time used in cattle would provide an appropriate margin of safety if used in sheep.

Original languageEnglish (US)
Pages (from-to)36-45
Number of pages10
JournalJournal of Veterinary Pharmacology and Therapeutics
Volume14
Issue number1
DOIs
StatePublished - 1991
Externally publishedYes

Fingerprint

Sulfamethazine
pharmacokinetics
Sheep
Pharmacokinetics
Safety
sheep
blood serum
bioavailability
mouth
animals
dosage
margin of safety
blood chemistry
half life
skeletal muscle
necropsy
water
kidneys
Biological Availability
iron

ASJC Scopus subject areas

  • Pharmacology
  • veterinary(all)

Cite this

Pharmacokinetics, safety and tissue residues of sustained‐release sulfamethazine in sheep. / BULGIN, M. S.; Lane, V Michael; ARCHER, T. E.; BAGGOT, J. D.; CRAIGMILL, A. L.

In: Journal of Veterinary Pharmacology and Therapeutics, Vol. 14, No. 1, 1991, p. 36-45.

Research output: Contribution to journalArticle

BULGIN, M. S. ; Lane, V Michael ; ARCHER, T. E. ; BAGGOT, J. D. ; CRAIGMILL, A. L. / Pharmacokinetics, safety and tissue residues of sustained‐release sulfamethazine in sheep. In: Journal of Veterinary Pharmacology and Therapeutics. 1991 ; Vol. 14, No. 1. pp. 36-45.
@article{9bfd84d397b94f1db779f30495d71bff,
title = "Pharmacokinetics, safety and tissue residues of sustained‐release sulfamethazine in sheep",
abstract = "Concentration‐time profiles and the rates of absorption, extent of distribution and half‐lives of sulfamethazine (SMZ), administered intravenously, orally as a water solution and as a sustained‐release formulation (CalfSpanrr̀) were determined in 10 healthy sheep. The geometric mean half‐life of elimination of i.v. SMZ was 10.8 h, compared to 14.3 h for the sustained‐release preparation (CalfSpanrr̀) and 4.3 h for the oral water solution. Blood levels of SMZ were at or above 50 ng/ml for more than 48 h for CalfSpanr̀, for 24 h after i.v. SMZ (100 mg/kg body wt), and for less than 24 h after p.o. SMZ (100 mg/kg body wt). The mean bioavailability of the oral SMZ solution was 58.3{\%} (AUCp.oJAUCi.v). The estimated bioavailability of the CalfSpanr̀ preparation was 52.5{\%}. The safety of the sustained‐release preparation was tested by dosing sheep with multiples (one, three and five times) of the recommended dose (one tablet, 8 g SMZ, per 20 kg body wt), once a day for 3 days. Clinical blood chemistries showed a significant increase in serum iron, and a decrease in serum phosphorus in animals treated at the 3x and 5x dose levels. Necropsies of the 5x dose animals did not show any gross signs that could be attributed to SMZ, and histological examination of tissues from the 5x animals revealed no organ pathology. Residues of SMZ in liver, fat, kidney and skeletal muscle were measured in 20 animals that received one bolus per 20 kg body wt. The results indicate that SMZ residues are cleared rapidly, and are at or below the tolerance level of 0.1 mg/kg within 8 days after dosing so that the 18‐day withdrawal time used in cattle would provide an appropriate margin of safety if used in sheep.",
author = "BULGIN, {M. S.} and Lane, {V Michael} and ARCHER, {T. E.} and BAGGOT, {J. D.} and CRAIGMILL, {A. L.}",
year = "1991",
doi = "10.1111/j.1365-2885.1991.tb00802.x",
language = "English (US)",
volume = "14",
pages = "36--45",
journal = "Journal of Veterinary Pharmacology and Therapeutics",
issn = "0140-7783",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Pharmacokinetics, safety and tissue residues of sustained‐release sulfamethazine in sheep

AU - BULGIN, M. S.

AU - Lane, V Michael

AU - ARCHER, T. E.

AU - BAGGOT, J. D.

AU - CRAIGMILL, A. L.

PY - 1991

Y1 - 1991

N2 - Concentration‐time profiles and the rates of absorption, extent of distribution and half‐lives of sulfamethazine (SMZ), administered intravenously, orally as a water solution and as a sustained‐release formulation (CalfSpanrr̀) were determined in 10 healthy sheep. The geometric mean half‐life of elimination of i.v. SMZ was 10.8 h, compared to 14.3 h for the sustained‐release preparation (CalfSpanrr̀) and 4.3 h for the oral water solution. Blood levels of SMZ were at or above 50 ng/ml for more than 48 h for CalfSpanr̀, for 24 h after i.v. SMZ (100 mg/kg body wt), and for less than 24 h after p.o. SMZ (100 mg/kg body wt). The mean bioavailability of the oral SMZ solution was 58.3% (AUCp.oJAUCi.v). The estimated bioavailability of the CalfSpanr̀ preparation was 52.5%. The safety of the sustained‐release preparation was tested by dosing sheep with multiples (one, three and five times) of the recommended dose (one tablet, 8 g SMZ, per 20 kg body wt), once a day for 3 days. Clinical blood chemistries showed a significant increase in serum iron, and a decrease in serum phosphorus in animals treated at the 3x and 5x dose levels. Necropsies of the 5x dose animals did not show any gross signs that could be attributed to SMZ, and histological examination of tissues from the 5x animals revealed no organ pathology. Residues of SMZ in liver, fat, kidney and skeletal muscle were measured in 20 animals that received one bolus per 20 kg body wt. The results indicate that SMZ residues are cleared rapidly, and are at or below the tolerance level of 0.1 mg/kg within 8 days after dosing so that the 18‐day withdrawal time used in cattle would provide an appropriate margin of safety if used in sheep.

AB - Concentration‐time profiles and the rates of absorption, extent of distribution and half‐lives of sulfamethazine (SMZ), administered intravenously, orally as a water solution and as a sustained‐release formulation (CalfSpanrr̀) were determined in 10 healthy sheep. The geometric mean half‐life of elimination of i.v. SMZ was 10.8 h, compared to 14.3 h for the sustained‐release preparation (CalfSpanrr̀) and 4.3 h for the oral water solution. Blood levels of SMZ were at or above 50 ng/ml for more than 48 h for CalfSpanr̀, for 24 h after i.v. SMZ (100 mg/kg body wt), and for less than 24 h after p.o. SMZ (100 mg/kg body wt). The mean bioavailability of the oral SMZ solution was 58.3% (AUCp.oJAUCi.v). The estimated bioavailability of the CalfSpanr̀ preparation was 52.5%. The safety of the sustained‐release preparation was tested by dosing sheep with multiples (one, three and five times) of the recommended dose (one tablet, 8 g SMZ, per 20 kg body wt), once a day for 3 days. Clinical blood chemistries showed a significant increase in serum iron, and a decrease in serum phosphorus in animals treated at the 3x and 5x dose levels. Necropsies of the 5x dose animals did not show any gross signs that could be attributed to SMZ, and histological examination of tissues from the 5x animals revealed no organ pathology. Residues of SMZ in liver, fat, kidney and skeletal muscle were measured in 20 animals that received one bolus per 20 kg body wt. The results indicate that SMZ residues are cleared rapidly, and are at or below the tolerance level of 0.1 mg/kg within 8 days after dosing so that the 18‐day withdrawal time used in cattle would provide an appropriate margin of safety if used in sheep.

UR - http://www.scopus.com/inward/record.url?scp=0026021503&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026021503&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2885.1991.tb00802.x

DO - 10.1111/j.1365-2885.1991.tb00802.x

M3 - Article

C2 - 2038093

AN - SCOPUS:0026021503

VL - 14

SP - 36

EP - 45

JO - Journal of Veterinary Pharmacology and Therapeutics

JF - Journal of Veterinary Pharmacology and Therapeutics

SN - 0140-7783

IS - 1

ER -